[Featured Stock] Kolmar BNH Rises 12% on Earnings Improvement Expectations from Overseas Expansion

The stock price of Kolmar BNH is on the rise. Expectations for improved performance due to expanded overseas expansion appear to be influencing the stock price.

At 9:30 AM on the 21st, Kolmar BNH was trading at 17,550 KRW, up 12.36% from the previous day.

Jang Ji-hye, a researcher at DS Investment & Securities, stated, "Kolmar BNH's consolidated sales this year are expected to reach 662.3 billion KRW, a 14% increase compared to the same period last year, and operating profit is projected to rise 34% to 40.7 billion KRW." She added, "With the launch of HemoHim-G and regional promotions by major clients, diversification into regions such as Russia and ASEAN beyond China is occurring, which is positive."

Researcher Jang continued, "Kangso Kolmar is expected to see sales growth through existing client growth and the addition of new local clients," and "Although the domestic market is sluggish, aggressive order acquisition activities will expand the volume of Original Design Manufacturing (ODM), leading to growth." She also added, "With the operation of the Sejong Plant 3 this year, based on stable large-scale production capacity (CAPA), the volume of domestic and overseas health functional food ODM will increase."